Burgeoning Gaucher Disease Treatment Market to Witness Significant Growth Owing to Promising Drug Pipeline and Increasing Diagnosis Rates
Market Overview: Gaucher disease is a rare genetic disorder caused by the buildup of fatty substances called glycosphingolipids in macrophages in certain organs such as spleen, liver and bone marrow. The signs and symptoms can range from relatively mild to severe and may include fatigue, bone pain and fractures. Currently, enzyme replacement therapy (ERT) is the standard treatment approved by...
0 Comments 0 Shares 814 Views 0 Reviews
Sponsored